FDA Inspection 936889 — Pentagon Blood Collection Site
The FDA completed an inspection of Pentagon Blood Collection Site on Jul 29, 2015 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 29, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Washington, DC (United States)